NCM · Biotechnology

ELUT (ELUT) Stock

$0.86 -5.33% NCM: ELUT Healthcare

Valuation

MetricValue
Price$0.86
Market Cap$37.88M
P/E Ratio-1.24
P/B Ratio1.59
P/S Ratio3.04
EPS (TTM)$-0.79
52-Week High$2.64
52-Week Low$0.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE189.29%
ROA85.48%
ROCE-66.67%
Gross Margin-158.33%
Operating Margin-150.00%
Net Margin3.12%
Debt/Equity0.27
Current Ratio2.24

Annual Financials (USD)

Metric20212022202320242025
Revenue$47.0M$24.0M$25.0M$24.0M$12.0M
Operating Profit$-23.0M$-35.0M$-31.0M$-36.0M$-18.0M
Net Profit$-25.0M$-33.0M$-38.0M$-54.0M$53.0M
EPS$-2.38$-2.38$-2.07$-1.86$-0.79
Op Margin-48.6%-147.6%-123.4%-146.3%-149.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$67.0M$69.0M$43.0M$36.0M$62.0M
Total Liabilities$54.0M$74.0M$82.0M$82.0M$35.0M
Cash$30.0M$17.0M$19.0M$13.0M$36.0M
Borrowings$23.0M$25.0M$24.0M$25.0M$8.0M

Latest News

Elutia to Present at Planet MicroCap Showcase 2026 on June 17th GlobeNewswire · Jun 11, 2026 Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · May 18, 2026 Elutia (ELUT) Q1 2026 Earnings Transcript Motley Fool · May 15, 2026 Elutia Inc. Q1 2026 Earnings Call Summary Moby · May 15, 2026 Elutia Inc (ELUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Revenue Shifts GuruFocus.com · May 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-15.0M$-21.0M$-22.0M$-23.0M$-45.0M
Investing Cash Flow$-1.0M$-1.0M$14.0M$-1.0M$77.0M
Financing Cash Flow$-3.0M$-3.0M$12.0M$19.0M$-1.0M
Net Cash Flow$-9.0M$-13.0M$2.0M$-6.0M$23.0M
Free Cash Flow$-16.0M$-22.0M$-22.0M$-23.0M$-47.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-93.27%
Quick Ratio1.94
Interest Coverage—
Return 1Y-52.53%
Return 3Y-60.91%
Return 5Y-87.55%

Ownership

Insiders Held3.51%
Institutions Held45.56%
Institutions Float Held47.22%
Institutional HolderSharesReport Date
AIGH Capital Management LLC3,595,2502026-03-31
Nantahala Capital Management, LLC3,184,9472026-03-31
Knollwood Investment Advisory, LLC2,556,7242026-03-31
SilverArc Capital Management, LLC2,498,0202026-03-31
Vanguard Capital Management LLC1,023,6992026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About ELUT

ELUT is led by CEO C. Randal Mills, employs 51 people, headquartered in US, publicly traded since 2020.

ELUT stock trades at $0.86 with a market capitalization of $37.88M. The stock is valued at a price-to-earnings (P/E) ratio of -1.24, price-to-book of 1.59, price-to-sales of 3.04. Over the past 52 weeks the stock has ranged between $0.50 and $2.64, and currently trades 67.4% below its 52-week high.

On profitability, ELUT generates a return on equity (ROE) of 189.29% — well above the market average, a sign of a high-quality business, return on capital employed of -66.67%, an operating margin of -150.00%, a net profit margin of 3.12%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides